openPR Logo
Press release

Antiretroviral Therapy Market Forecast by Value , Providers, Companies, Government Bodies & Regulating Authorities

Antiretroviral Therapy Market Forecast by Value , Providers,

The global antiretroviral therapy market is anticipated to reach US$35.14 billion in 2024. The market is predicted to experience growth at a CAGR of 3.40% during the period spanning 2020-2024. The growth in the antiretroviral therapy market is supported by various factors including rising prevalence of HIV, growing access to antiretroviral therapy, increasing intake of PrEP and surging prevalence of mother-to-child transmission of HIV.

The market is also expected to face a trend of increasing use of illicit drugs. The global antiretroviral therapy market is also prone to certain challenges like increasing voluntary male circumcisions and huge cost of treatment. The growing prevalence of COVID-19 is also expected to boost the market as the healthcare spending by government would rise. Moreover, patients suffering from HIV are more prone to get infected by COVID-19 virus.

Grab Your Free Sample Report With Detailed TOC, Tables, Figures, Charts @ https://www.researchmoz.us/enquiry.php?type=S&repid=2696532

The global antiretroviral therapy market by drug type can be segmented into the following: NRTI, NNRTI, protease inhibitors and integrase inhibitors. The dominant share of the market in 2019 was held by NRTI, followed by NNRTI, protease inhibitors and integrase inhibitors.

The global antiretroviral therapy market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the global antiretroviral therapy market, supported by various factors like increasing funds on research & development activity and surging number of coronavirus infected cases.

Scope of the report:

The report provides a comprehensive analysis of the global antiretroviral therapy market with potential impact of COVID-19.
The major regional markets (North America, Europe and APAC) have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Gilead Sciences, GSK, Roche Holding, Boehringer Ingelheim, Cipla and Abbvie) are also presented in detail.

Browse Detailed TOC, Tables, Figures, Charts @ https://www.researchmoz.us/global-antiretroviral-therapy-market-nrti-nnrti-protease-inhibitors-integrase-inhibitors-insights-forecast-with-potential-impact-of-covid19-20202024-report.html

Key Target Audience:

Antiretroviral Therapy Providers
Hospitals/Clinics
Healthcare Companies
End Users (Businesses/Consumers)
Investment Banks
Government Bodies & Regulating Authorities
Table of Content

1. Market Overview
1.1 Antiretroviral Therapy
1.2 Types of Antiretroviral Drugs
1.3 Side Effects of HIV Drugs

2. Impact of COVID-19
2.1 Global Impact of COVID-19
2.2 Change in Organic Traffic
2.3 Rising Prevalence of COVID-19
2.4 Impact on Healthcare Spending

3. Market Analysis
3.1 Global Antiretroviral Therapy Market by Value
3.2 Global Antiretroviral Therapy Market Forecast by Value
3.3 Global Antiretroviral Therapy Market by Drug Type
3.3.1 Global NRTI Antiretroviral Therapy Market by Value
3.3.2 Global NRTI Antiretroviral Therapy Market Forecast by Value
3.3.3 Global NNRTI Antiretroviral Therapy Market by Value
3.3.4 Global NNRTI Antiretroviral Therapy Market Forecast by Value
3.3.5 Global Protease Inhibitors Antiretroviral Therapy Market by Value
3.3.6 Global Protease Inhibitors Antiretroviral Therapy Market Forecast by Value
3.3.7 Global Integrase Inhibitors Antiretroviral Therapy Market by Value
3.3.8 Global Integrase Inhibitors Antiretroviral Therapy Market Forecast by Value
3.3.9 Global Other Drug Antiretroviral Therapy Market by Value
3.3.10 Global Other Drug Antiretroviral Therapy Market Forecast by Value
3.4 Global Antiretroviral Therapy Market by Region

4. Regional Market
4.1 North America
4.1.1 North America Antiretroviral Therapy Market by Value
4.1.2 North America Antiretroviral Therapy Market Forecast by Value
4.2 Europe
4.2.1 Europe Antiretroviral Therapy Market by Value
4.2.2 Europe Antiretroviral Therapy Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Antiretroviral Therapy Market by Value
4.3.2 Asia Pacific Antiretroviral Therapy Market Forecast by Value
4.4 RoW
4.4.1 RoW Antiretroviral Therapy Market by Value
4.4.2 RoW Antiretroviral Therapy Market Forecast by Value

Continue…

Make An Enquiry for Discount Before Buying The Report: https://www.researchmoz.us/enquiry.php?type=D&repid=2696532

About ResearchMoz:

Researchmoz is the one stop online destination to find and buy market research reports & Industry Analysis. We help enterprises of all sizes and from wide range of Industries Bridge the gap between success and failure, mainly through insights and analytics solutions offered in our reports. Researchmoz has a dedicated team to identify the most prominent aspects of business landscape and develop a framework in including them in the ongoing reports. All our business intelligence solutions that we provide or offer through third parties help them achieve this end. Our seasoned analysts sometimes double as consultants to provide analytics-driven insights, and help you move ahead of your competitors. The expertise that tens of thousands of reports contain strive to offer tailor-made solutions to meet your emerging needs. We help decipher the trends and proclivities of people to help companies understand their clients.

For More Information Kindly Contact: Contact:
ResearchMoz
Mr. Rohit Bhisey,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Media Release: https://www.researchmoz.us/pressrelease
Browse More Reports Visit @ http://marketresearchlatestreports.blogspot.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiretroviral Therapy Market Forecast by Value , Providers, Companies, Government Bodies & Regulating Authorities here

News-ID: 2221957 • Views:

More Releases for NRTI

Antiviral APIs Lamivudine, TDF and TAF Research:CAGR of 15.0% during the forecas …
Antiviral APIs Lamivudine, TDF and TAF Market Summary Lamivudine, Tenofovir Disoproxil Fumarate (TDF), and Tenofovir Alafenamide (TAF) are antiviral active pharmaceutical ingredients (APIs) commonly used in the treatment of chronic hepatitis B and HIV infections. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that blocks viral replication by incorporating into viral DNA. TDF and TAF are prodrugs of tenofovir, another NRTI, which inhibit reverse transcriptase and prevent the virus from multiplying.
Abacavir Market Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates …
Abacavir Market Size The global market for Abacavir was estimated to be worth US$ 688.2 million in 2023 and is forecast to a readjusted size of US$ 1194.5 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030 View sample report https://reports.valuates.com/request/sample/QYRE-Auto-11N8047/Global_Abacavir_Market_Insights_and_Forecast_to_2028 Abacavir Market Trends The Abacavir market size is experiencing steady growth due to the increasing prevalence of HIV/AIDS and the rising demand for antiretroviral therapies. Abacavir, a key nucleoside reverse
Antiviral Combination Therapies Market May Set New Growth Story
The latest research study released by AMA on the Antiviral Combination Therapies Market offers over 181 pages of analysis on business strategies employed by key and emerging industry players. It provides insights into current market developments, landscape, technologies, drivers, opportunities, market outlook, and status. The market study is segmented by key regions driving market growth. The Antiviral Combination Therapies study combines qualitative and quantitative market data, primarily collected and validated
Antiviral Combination Therapies Market Size is Expected to Reach USD 71.4 billio …
Antiviral combination therapies involve the strategic use of two or more antiviral drugs with complementary mechanisms of action to maximize treatment efficacy and minimize the development of drug resistance. By targeting multiple viral targets or pathways simultaneously, combination therapies can achieve synergistic effects, improve virologic suppression, and enhance clinical outcomes in patients with viral infections. Common examples include the use of dual or triple therapy regimens for HIV/AIDS, hepatitis C,
Antiviral Combination Therapies Market: Competitive Dynamics & Global Outlook 20 …
Global Info Research offers a latest published report on Antiviral Combination Therapies Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Antiviral Combination Therapies Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
What's driving the Antiretroviral Drugs Market trends? Johnson & Johnson, Merck …
The ‘Antiretroviral Drugs Market’ research report assembled by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players. Over the recent years, Antiretroviral drugs market has been witnessing growth on account of several